The importance of MET signaling in intrinsic resistance to TKIs was also underlined by another Japanese cohort, in which overexpression of the MET ligand HGF was detected in 29% of EGFRm+ NSCLC patients not responding to first-generation EGFR-TKIs [94]. Here, HGF is linked to non-small cell lung carcinoma.